Breadcrumb

[A18-87] Fingolimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V

Overview

Overview

Commission: Commission awarded on 2018-12-19 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Extract of dossier assessment  [PDF, 372 kB]Further documents
Note:

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Contact address:to the contact form
Linked projects: [A19-42] Fingolimod (multiple sclerosis in children and adolescents) - Addendum to Commission A18-87
Status: Commission completed

[A15-48] Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed

[A15-12] Fingolimod - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Status: Commission completed

[A14-21] Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Status: Commission completed

[A11-23] Fingolimod - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2019-04-01 Extract of dossier assessment 372 kBPDFdownload file
2019-04-01 Dossier assessment (German version) 668 kBPDFdownload file

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.


At a glance

Accompanying information

Extract of dossier assessment

  File-Icon  Fingolimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V [PDF, 372 kB]

More

Federal Joint Committee (G-BA)

2019-06-20 A G-BA decision was published.

G-BA documents on this decision



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close